Hepatitis B

P47 De-novo antiviral therapy with nucleos(t)ide analogues in ‘real-life’ patients with chronic hepatitis B infection: comparison of virological responses between lamivudine + adefovir vs entecavir vs tenofovir therapy
I Carey, H Nguyen DorothyJoe, M Al-Freah, S Knighton, M Bruce, A Suddle, P M Harrison, K Agarwal

Gut Sep 2011, 60 (Suppl 2) A22-A23; DOI: 10.1136/gutjnl-2011-300857a.47
P23 Comparison of enhanced liver fibrosis test and transient elastography for the non-invasive assessment of liver fibrosis in chronic hepatitis B
P M Trembling, P Lampertico, J Parkes, S Tanwar, M Viganú, F Facchetti, M Colombo, W M Rosenberg

Gut Sep 2011, 60 (Suppl 2) A10-A11; DOI: 10.1136/gutjnl-2011-300857a.23
Evolutionary patterns of hepatitis B virus quasispecies under different selective pressures: correlation with antiviral efficacy
Feng Liu, Li Chen, De-Min Yu, Lin Deng, Rong Chen, Yin Jiang, Liang Chen, Su-Yuan Huang, Jia-Lun Yu, Qi-Ming Gong, Xin-Xin Zhang

Gut Sep 2011, 60 (9) 1269-1277; DOI: 10.1136/gut.2010.226225
Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study
George V Papatheodoridis, Spilios Manolakopoulos, Giota Touloumi, Georgia Vourli, Maria Raptopoulou-Gigi, Irini Vafiadis-Zoumbouli, Themistoklis Vasiliadis, Kostas Mimidis, Charalambos Gogos, Ioannis Ketikoglou, Emanuel K Manesis, for the HEPNET. Greece Cohort Study Group

Gut Aug 2011, 60 (8) 1109-1116; DOI: 10.1136/gut.2010.221846
Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years
Dominique Roulot, Jean-Luc Costes, Jean-François Buyck, Ursula Warzocha, Nicolas Gambier, Sébastien Czernichow, Hervé Le Clesiau, Michel Beaugrand

Gut Jul 2011, 60 (7) 977-984; DOI: 10.1136/gut.2010.221382
Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B
S J Patterson, J George, S I Strasser, A U Lee, W Sievert, A J Nicoll, P V Desmond, S K Roberts, S Locarnini, S Bowden, P W Angus

Gut Feb 2011, 60 (2) 247-254; DOI: 10.1136/gut.2010.223206
Prevalence of occult hepatitis B infection in a highly endemic area for chronic hepatitis B: a study of a large blood donor population
Man-Fung Yuen, Cheuk-Kwong Lee, Danny Ka-Ho Wong, James Fung, Ivan Hung, Axel Hsu, David Yiu-Kuen But, Ting-Kin Cheung, Pierre Chan, John Chi-Hang Yuen, Frederic Khe-Cheong Fung, Wai-Kay Seto, Che-Kit Lin, Ching-Lung Lai

Gut Oct 2010, 59 (10) 1389-1393; DOI: 10.1136/gut.2010.209148
Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study
Maria Stepanova, Nila Rafiq, Zobair M Younossi

Gut Oct 2010, 59 (10) 1410-1415; DOI: 10.1136/gut.2010.213553
Managing HBV in patients with impaired immunity
Karsten Wursthorn, Heiner Wedemeyer, Michael P Manns

Gut Oct 2010, 59 (10) 1430-1445; DOI: 10.1136/gut.2009.195834
Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B
G L-H Wong, V W-S Wong, P C-L Choi, A W-H Chan, A M-L Chim, K K-L Yiu, H-Y Chan, F K-L Chan, J J-Y Sung, H L-Y Chan

Gut Jan 2009, 58 (1) 111-117; DOI: 10.1136/gut.2008.157735

Main menu

Hepatitis B

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Hepatitis B

Pages